{"title":"利用微血管血流成像和横波弹性成像的多模态超声引导细针穿刺甲状腺病变:一项基于模式的微血管分类的前瞻性研究。","authors":"Jiamin Chen, Jing Zhong, Yu Zhuang, Bixue Deng, Jiayi Hong, Yuhong Lin, Zhongzhen Su, Xin Wen","doi":"10.1089/thy.2024.0586","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Background:</i></b> Most current guidelines recommend fine-needle aspiration (FNA) biopsy of thyroid nodules based on grayscale ultrasound (GUS) features, but the biopsy rate for benign nodules remains high. Our aim was to construct a new pattern-based microvascular classification (PBMC) for thyroid nodules to develop and validate predictive multimodality US models based on GUS, microvascular flow imaging, and shear wave elastography, and compare FNA decision accuracy with the American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS). <b><i>Methods:</i></b> This prospective study included consecutive patients with thyroid nodules who underwent multimodality US examinations from September 2022 to December 2023. Using PBMC, lesions were divided into three categories: malignant signs (convergence sign, piercing sign, and spoke wheel sign), benign signs (ring sign), and other vascular patterns. Univariate and multivariable logistic regression analyses were conducted to determine the odds ratios (ORs) of US features, including vascular signs, and construct predictive models based on multimodality US. Multimodality US models were validated with internal cross-validation and evaluated based on discrimination, calibration, and decision curve analyses. <b><i>Results:</i></b> Overall, 793 thyroid nodules confirmed using pathological analysis (248 benign and 545 malignant) in 599 participants (mean age, 43 years ±11 [SD]) were included. In univariate logistic regression analyses, malignant vascular signs showed a positive association with malignant nodules (OR: 10.43, 95% confidence interval [CI]: 5.76, 18.88; <i>p</i> < 0.01), whereas benign vascular signs were inversely associated with malignancy (OR: 0.10, 95% CI: 0.06, 0.16; <i>p</i> < 0.01). Four multivariable models incorporated GUS features, Young's modulus, and PBMC. The highest area under the receiver operating characteristic curve (AUC) was 0.95 (95% CI: 0.82, 0.97) for the multimodality US model, and the lowest AUC was 0.62 (95% CI: 0.57, 0.66) for ACR TI-RADS based on GUS (<i>p</i> < 0.001). At a 71% risk threshold, multimodality US avoided 27% (95% CI: 21, 34) of FNA procedures, compared with 13% (95% CI: 0, 38) with TI-RADS (<i>p</i> < 0.001). <b><i>Conclusion:</i></b> Visual assessment of microvascular morphology patterns may improve differentiation of benign and malignant thyroid nodules and potentially reduce the risk of unnecessary biopsy of benign thyroid nodules.</p>","PeriodicalId":23016,"journal":{"name":"Thyroid","volume":" ","pages":"516-526"},"PeriodicalIF":5.8000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Multimodality Ultrasound Utilizing Microvascular Flow Imaging and Shear Wave Elastography to Guide Fine-Needle Aspiration of Thyroid Lesions: A Prospective Study Validating Pattern-Based Microvascular Classification.\",\"authors\":\"Jiamin Chen, Jing Zhong, Yu Zhuang, Bixue Deng, Jiayi Hong, Yuhong Lin, Zhongzhen Su, Xin Wen\",\"doi\":\"10.1089/thy.2024.0586\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b><i>Background:</i></b> Most current guidelines recommend fine-needle aspiration (FNA) biopsy of thyroid nodules based on grayscale ultrasound (GUS) features, but the biopsy rate for benign nodules remains high. Our aim was to construct a new pattern-based microvascular classification (PBMC) for thyroid nodules to develop and validate predictive multimodality US models based on GUS, microvascular flow imaging, and shear wave elastography, and compare FNA decision accuracy with the American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS). <b><i>Methods:</i></b> This prospective study included consecutive patients with thyroid nodules who underwent multimodality US examinations from September 2022 to December 2023. Using PBMC, lesions were divided into three categories: malignant signs (convergence sign, piercing sign, and spoke wheel sign), benign signs (ring sign), and other vascular patterns. Univariate and multivariable logistic regression analyses were conducted to determine the odds ratios (ORs) of US features, including vascular signs, and construct predictive models based on multimodality US. Multimodality US models were validated with internal cross-validation and evaluated based on discrimination, calibration, and decision curve analyses. <b><i>Results:</i></b> Overall, 793 thyroid nodules confirmed using pathological analysis (248 benign and 545 malignant) in 599 participants (mean age, 43 years ±11 [SD]) were included. In univariate logistic regression analyses, malignant vascular signs showed a positive association with malignant nodules (OR: 10.43, 95% confidence interval [CI]: 5.76, 18.88; <i>p</i> < 0.01), whereas benign vascular signs were inversely associated with malignancy (OR: 0.10, 95% CI: 0.06, 0.16; <i>p</i> < 0.01). Four multivariable models incorporated GUS features, Young's modulus, and PBMC. The highest area under the receiver operating characteristic curve (AUC) was 0.95 (95% CI: 0.82, 0.97) for the multimodality US model, and the lowest AUC was 0.62 (95% CI: 0.57, 0.66) for ACR TI-RADS based on GUS (<i>p</i> < 0.001). At a 71% risk threshold, multimodality US avoided 27% (95% CI: 21, 34) of FNA procedures, compared with 13% (95% CI: 0, 38) with TI-RADS (<i>p</i> < 0.001). <b><i>Conclusion:</i></b> Visual assessment of microvascular morphology patterns may improve differentiation of benign and malignant thyroid nodules and potentially reduce the risk of unnecessary biopsy of benign thyroid nodules.</p>\",\"PeriodicalId\":23016,\"journal\":{\"name\":\"Thyroid\",\"volume\":\" \",\"pages\":\"516-526\"},\"PeriodicalIF\":5.8000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Thyroid\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1089/thy.2024.0586\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/4/21 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thyroid","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/thy.2024.0586","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/21 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
Multimodality Ultrasound Utilizing Microvascular Flow Imaging and Shear Wave Elastography to Guide Fine-Needle Aspiration of Thyroid Lesions: A Prospective Study Validating Pattern-Based Microvascular Classification.
Background: Most current guidelines recommend fine-needle aspiration (FNA) biopsy of thyroid nodules based on grayscale ultrasound (GUS) features, but the biopsy rate for benign nodules remains high. Our aim was to construct a new pattern-based microvascular classification (PBMC) for thyroid nodules to develop and validate predictive multimodality US models based on GUS, microvascular flow imaging, and shear wave elastography, and compare FNA decision accuracy with the American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS). Methods: This prospective study included consecutive patients with thyroid nodules who underwent multimodality US examinations from September 2022 to December 2023. Using PBMC, lesions were divided into three categories: malignant signs (convergence sign, piercing sign, and spoke wheel sign), benign signs (ring sign), and other vascular patterns. Univariate and multivariable logistic regression analyses were conducted to determine the odds ratios (ORs) of US features, including vascular signs, and construct predictive models based on multimodality US. Multimodality US models were validated with internal cross-validation and evaluated based on discrimination, calibration, and decision curve analyses. Results: Overall, 793 thyroid nodules confirmed using pathological analysis (248 benign and 545 malignant) in 599 participants (mean age, 43 years ±11 [SD]) were included. In univariate logistic regression analyses, malignant vascular signs showed a positive association with malignant nodules (OR: 10.43, 95% confidence interval [CI]: 5.76, 18.88; p < 0.01), whereas benign vascular signs were inversely associated with malignancy (OR: 0.10, 95% CI: 0.06, 0.16; p < 0.01). Four multivariable models incorporated GUS features, Young's modulus, and PBMC. The highest area under the receiver operating characteristic curve (AUC) was 0.95 (95% CI: 0.82, 0.97) for the multimodality US model, and the lowest AUC was 0.62 (95% CI: 0.57, 0.66) for ACR TI-RADS based on GUS (p < 0.001). At a 71% risk threshold, multimodality US avoided 27% (95% CI: 21, 34) of FNA procedures, compared with 13% (95% CI: 0, 38) with TI-RADS (p < 0.001). Conclusion: Visual assessment of microvascular morphology patterns may improve differentiation of benign and malignant thyroid nodules and potentially reduce the risk of unnecessary biopsy of benign thyroid nodules.
期刊介绍:
This authoritative journal program, including the monthly flagship journal Thyroid, Clinical Thyroidology® (monthly), and VideoEndocrinology™ (quarterly), delivers in-depth coverage on topics from clinical application and primary care, to the latest advances in diagnostic imaging and surgical techniques and technologies, designed to optimize patient care and outcomes.
Thyroid is the leading, peer-reviewed resource for original articles, patient-focused reports, and translational research on thyroid cancer and all thyroid related diseases. The Journal delivers the latest findings on topics from primary care to clinical application, and is the exclusive source for the authoritative and updated American Thyroid Association (ATA) Guidelines for Managing Thyroid Disease.